- Report
- December 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- May 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- March 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 191 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- October 2025
- 88 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 135 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 90 Pages
United States
From €3459EUR$3,950USD£3,003GBP
- Report
- March 2025
- 120 Pages
North America
From €3503EUR$4,000USD£3,041GBP
- Report
- November 2025
- 97 Pages
Asia Pacific
From €3459EUR$3,950USD£3,003GBP
- Report
- November 2025
- 100 Pages
Europe
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 81 Pages
Africa, Middle East
From €3022EUR$3,450USD£2,623GBP
- Report
- October 2025
- 100 Pages
Europe
From €3459EUR$3,950USD£3,003GBP
- Report
- January 2024
- 314 Pages
Global
From €5187EUR$6,130USD£4,350GBP
- Report
- August 2024
- 307 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- May 2023
- 202 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- May 2024
- 311 Pages
Global
From €2146EUR$2,450USD£1,862GBP

High Throughput Sequencing (HTS) is a biotechnology technique used to rapidly sequence large amounts of DNA or RNA. It is used to identify genetic variations, detect mutations, and analyze gene expression. HTS is used in a variety of applications, including drug discovery, diagnostics, and personalized medicine. It is also used in research to study the genetic basis of diseases, to identify biomarkers, and to understand the evolution of species.
HTS has revolutionized the biotechnology industry, allowing researchers to quickly and accurately sequence large amounts of genetic material. This has enabled the development of new treatments and diagnostics, as well as the identification of new biomarkers.
Companies in the HTS market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10X Genomics. Show Less Read more